Quanterix Co. (NASDAQ:QTRX) Holdings Boosted by State Street Corp

State Street Corp lifted its position in Quanterix Co. (NASDAQ:QTRX) by 2.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 836,443 shares of the company’s stock after buying an additional 18,050 shares during the quarter. State Street Corp’s holdings in Quanterix were worth $10,840,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of QTRX. Portolan Capital Management LLC grew its position in Quanterix by 31.4% in the third quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock valued at $32,668,000 after acquiring an additional 602,656 shares during the period. Envestnet Asset Management Inc. raised its holdings in Quanterix by 2,261.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 209,731 shares of the company’s stock worth $2,771,000 after purchasing an additional 200,851 shares during the last quarter. Easterly Investment Partners LLC lifted its holdings in Quanterix by 26.5% in the third quarter. Easterly Investment Partners LLC now owns 876,133 shares of the company’s stock valued at $11,355,000 after buying an additional 183,387 shares during the period. Pier Capital LLC boosted its stake in Quanterix by 48.9% in the second quarter. Pier Capital LLC now owns 414,542 shares of the company’s stock valued at $5,476,000 after acquiring an additional 136,051 shares during the last quarter. Finally, Harbor Capital Advisors Inc. grew its holdings in Quanterix by 129.3% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 192,444 shares of the company’s stock worth $2,494,000 after acquiring an additional 108,503 shares during the period. 86.48% of the stock is owned by institutional investors and hedge funds.

Quanterix Price Performance

Shares of Quanterix stock opened at $11.07 on Friday. The company has a market capitalization of $424.86 million, a price-to-earnings ratio of -10.54 and a beta of 1.30. The business has a fifty day simple moving average of $12.29 and a two-hundred day simple moving average of $12.95. Quanterix Co. has a 1 year low of $9.87 and a 1 year high of $29.70.

Wall Street Analyst Weigh In

Separately, TD Cowen upped their price target on Quanterix from $13.50 to $16.00 and gave the company a “hold” rating in a research note on Wednesday, November 13th.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.